
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a veterinarian's order for one animal patient. Not FDA-approved.
No FDA-approved animal drug contains tramadol; Animal Drugs@FDA returns no tramadol products. Tramadol is an FDA-approved human opioid medicine, labeled for adults with pain severe enough to require an opioid when other treatments are inadequate. Tramadol is a federal Schedule IV controlled substance (21 CFR 1308.14). The Merck Veterinary Manual describes it as a weak mu opioid agonist that also blocks reuptake of norepinephrine and serotonin, says it may be used alone for mild pain or as part of a multimodal pain plan, and notes few clinical studies in animals. Compounded preparations are not FDA-approved and are dispensed only on a veterinarian's prescription for an individual animal.
The Merck Veterinary Manual lists side effects including a lowered seizure threshold, nausea and vomiting, and changed behavior in some animals. Merck says tramadol should not be used in animals that may have received MAO inhibitors such as selegiline, animals on SSRI antidepressants, or animals with recent seizures. Cats make much more of tramadol's active breakdown product than dogs and clear the drug more slowly. The human label's boxed warning covers addiction, abuse and misuse, life-threatening breathing problems and the danger of accidental swallowing, and the label warns of serotonin syndrome with other serotonin-affecting drugs. Keep it secured away from children and others. Ask your veterinarian or pharmacist about other medicines and supplements your animal takes.
With no approved animal product, tramadol use in animals is extralabel use of an approved human drug, permitted in nonfood-producing animal practice under 21 CFR 530.30 except when public health is threatened; compounding from an approved human product falls under 530.13(b), and 530.13(a) excludes compounding from bulk. Tramadol is not on FDA's GFI #256 office stock list; FDA lists it as under review for dogs, cats and horses and several zoo, exotic and other minor species (10/05/2026). Electronic prescribing of controlled substances is voluntary under DEA rules; CMS applies a prescriber-level threshold for Medicare Part D, and NABP reports at least 27 states and jurisdictions require e-prescribing in some form.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally